Inverse relationship between serum levels of interleukin-1βand testosterone in men with stable coronary artery disease

Hormone and Metabolic Research

Volumn 39, Issue 5, 2007, Pages 366-371

  Nettleship, J E ^a   Pugh, P J ^a,b   Channer, K S ^b,c   Jones, T ^a,d   Jones, R D ^a,e  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^d BARNSLEY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e NONE   (United Kingdom)

Author keywords

Coronary artery disease; Hypogonadism; IL 1 ; IL 10; Testosterone

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRATE; TESTOSTERONE; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEART MUSCLE ISCHEMIA; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

AGED; CORONARY ARTERIOSCLEROSIS; HUMANS; HYPOGONADISM; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 34249952109     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-976543     Document Type: Article

References (36)

1. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 2000; 21: 890-894
2. Pugh PJ, Morris PD, Hall J, Malkin CJ, Asif S, Jones RD, Channer KS, Jones TH. Prevalence of hypogonadism in men with coronary artery disease. J Am Coll Cardiol 2003; 41: 344A
3. Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996; 125: 1-13
4. Hak AE, Witteman JCM, De Jong FH, Geerlings MI, Hofman A, Pols HAP. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study. J Clin Endocrinol Metab 2002; 87: 3632-3639
5. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25-31
6. Malkin CJ, Pugh PJ, Jones TH, Channer KS. Testosterone for secondary prevention in men with ischaemic heart disease? Q J Med 2003; 96: 521-529
7. Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della MP, Bonfigli B, Volpe M, Chierchia SL. Acute anti-ischaemic effect of testosterone in men with coronary artery disease. Circulation 1999; 99: 1666-1670
8. Webb CM, Adamson DL, de Zeigler D, Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol 1999; 83: 437-439
9. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomised, double-blind, placebo-controlled study. Circulation 2000; 102: 1906-1911
10. Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, Channer KS. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 2004; 90: 871-876
11. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 1999; 84: 813-819
12. Bruck B, Brehme U, Gugel N, Hanke S, Finking G, Lutz C, Benda N, Schmahl FW, Haasis R, Hanke H. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997; 17: 2192-2199
13. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874
14. McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999; 99: 2317-2322
15. Williams MI, Ling SH, Dawood T, Hashimura K, Dai AZ, Li H, Liu JP, Funder JW, Sudhir K, Komesaroff PA. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metabol 2002; 87: 176-181
16. Mukherjee TK, Dinh H, Chaudhuri G, Nathan L. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: Implications in atherosclerosis. Proc Nat Acad Sci USA 2002; 99: 4055-4060
17. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS. Testosterone as a protective factor against atherosclerosis: Immunomodulation and influence upon plaque development and stability. J Endocrinol 2003; 178: 373-380
18. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004; 89: 3319-3318
19. Hall J, Pugh PJ, Jones RD, Corlett GL, Channer KS, Jones TH. Testosterone and pro-inflammatory cytokines in men with chronic heart failure. Endocrine Abst 2002; 3: 250
20. Tremblay RR, Dube JY. Plasma concentration of free and non-TEBG bound testosterone in women on oral contraceptives. Contraception 1974; 10: 599-605
21. Leszczynski D, Josephs MD, Foegh ML. IL-1-beta-stimulated leukocyte-endothelial adhesion is regulated, in part, by the cyclic-GMP-dependent signal transduction pathway. Scand J Immunol 1994; 39: 551-556
22. Libby P, Oodovas JM, Birinyi LK, Auger KR, Dinarello CA. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest 1986; 78: 1432-1438
23. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vas Biol 1996; 16: 1000-1006
24. Hasdai D, Scheinowitz M, Leibovitz E, Sclarovsky S, Eldar M, Barak V. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart 1996; 76: 24-28
25. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100: 793-798
26. Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE. Circulating levels of IL-1beta, a pro-thrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombol 2000; 9: 217-222
27. Balbay Y, Tikiz H, Baptiste RJ, Ayaz S, Sasmaz H, Korkmaz S. Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology 2001; 52: 109-114
28. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, Lejemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996; 28: 964-971
29. Sukovich DA, Kauser K, Shirley FD, Del Vecchio V, Halks-Miller M, Rubanyi GM. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice - Inhibition by 17 beta-estradiol. Arterioscler Thromb Vasc Biol 1998; 18: 1498-1505
30. Lentsch AB, Shanley TP, Sarma V, Ward PA. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997; 100: 2443-2448
31. Lacraz S, Nicod LP, Chicheportiche R, Wetgus HG, Dayer JM. IL-10 inhibits metaloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995; 96: 2304-2310
32. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85: E17-E24
33. Oslund LP, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, Fyfe AI. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vas Biol 1999; 19: 2847-2853
34. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001; 104: 746-749
35. Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, Marin JL, Betriu A, Sanz G. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J 2002; 144: 811-817
36. Waehre T, Halvorsen B, Damas JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Froland SS, Aukust P. Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 2002; 32: 803-810